On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid relief of depression in patients who have not been helped by existing…
Read More
Since 2008, when transcranial magnetic stimulation, or TMS, was approved by the U.S. Food and Drug Administration (FDA), it has been available to people whose depression has resisted conventional…
Read More
Although many studies in recent years have provided evidence that ketamine, an anesthetic drug, can provide rapid relief to people with deep depression, this research has not shed much light on what…
Read More
Some remarkable lessons have been learned by Dr. Helen Mayberg and her colleagues in their application of deep-brain stimulation in major depression. DBS is a pioneering experimental treatment for “…
Read More
Even in abbreviated form, a career synopsis of Scientific Council Member Helen Mayberg, M.D., presents a remarkable set of achievements.
Read More
